Despite the discrepancy in METTL3 expression levels in different hematological malignancies, METTL3 is upregulated in most tumor tissues and cell lines and is involved in disease progression and the maintenance of a cancer cell undifferentiated state. This evidence concerns the gene METTL3 and neoplasm.